APA

Pappo A. S., Bowman L. C., Furman W. L., Rao B. N., Kun L. E., Jenkins J. J., Crom W. R., Luo X., Kaste S. C., Avery L., Meyer W. H., Shapiro D. N. & Crist W. M. (19971031). A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. : Journal of pediatric hematology/oncology.

Chicago

Pappo A S, Bowman L C, Furman W L, Rao B N, Kun L E, Jenkins J J, Crom W R, Luo X, Kaste S C, Avery L, Meyer W H, Shapiro D N and Crist W M. 19971031. A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. : Journal of pediatric hematology/oncology.

Harvard

Pappo A. S., Bowman L. C., Furman W. L., Rao B. N., Kun L. E., Jenkins J. J., Crom W. R., Luo X., Kaste S. C., Avery L., Meyer W. H., Shapiro D. N. and Crist W. M. (19971031). A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. : Journal of pediatric hematology/oncology.

MLA

Pappo A S, Bowman L C, Furman W L, Rao B N, Kun L E, Jenkins J J, Crom W R, Luo X, Kaste S C, Avery L, Meyer W H, Shapiro D N and Crist W M. A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma. : Journal of pediatric hematology/oncology. 19971031.